|
139 PSNC complacent
over purchase profits, say Tories Shadow
health secretary Andrew Lansley has accused the Pharmaceutical Services
Negotiating Committee of complacency over the large recovery of excess
purchase profit that pharmacy contractors in England are now facing
PJ 2008;280:139
Full Text
139 Pharmacists to take lead in yellow
card campaign aimed at patients Community
pharmacists will take the lead role in a campaign by the Medicines and
Healthcare products Regulatory Agency to encourage the public to report
adverse drug reactions
PJ 2008;280:139
Full Text
140 New professional body
should be built from Society Pharmacy’s new professional body should be built on what is left of the Royal Pharmaceutical Society after its regulatory functions have been taken over by the planned General Pharmaceutical Council, the Pharmacists’ Defence Association has said
PJ 2008;280:140
Full Text
140 Fresh start needed for new professional
body Pharmacy’s new professional body should be established on the basis of a fresh start, rather than be constrained by the principles or practice of existing organisations. So says the NHS Scotland Directors of Pharmacy Group in its submission to the Clarke Inquiry
PJ 2008;280:140
Full Text
140 Deputy registrar sought Advertising
has started in order to fill the newly created post of deputy registrar of the
Royal Pharmaceutical Society
PJ 2008;280:140
Full Text
140 PSNC seeks recognition for additional workload
following changes to prescription sorting Recognition
of the workload associated with changes being made to sorting requirements for
prescriptions is being sought by the Pharmaceutical Services Negotiating Committee
PJ 2008;280:140
Full Text
141 Leaders needed to give
body credibility, Clarke told Creation of a professional body with real influence will require development of a cadre of leaders and experts to speak with authority on its behalf, says the Company Chemists’ Association in its response to the Clarke Inquiry. “Only then will the professional body be able to speak with a voice that is not constrained, but which is credible and authoritative,” it writes
PJ 2008;280:141
Full Text
141 Separate professional body backed by pharmacy
owners in Scotland Community pharmacy owners in
Scotland favour the creation of a separate professional body, according to a
poll carried out by Community Pharmacy Scotland
PJ 2008;280:141
Full Text
141 Further information issued on prescription
charge changes in Scotland Pharmacists in Scotland
are being sent information this week about changes to NHS prescription charges
that will take place in April 2008
PJ 2008;280:141
Full Text
142 Pharmacies say EPS not
yet a viable proposition GP surgeries are not yet
producing enough barcoded prescriptions to make dispensing via the electronic
prescription service feasible, according to some pharmacy groups. The latest
data from NHS Connecting for Health show that an average of 20 per cent of daily
prescriptions are prescribed electronically but only 2 per cent are dispensed
via the service
PJ 2008;280:142
Full Text
142 Community pharmacists should be able to
call on hospital pharmacists for support Pharmacists
working in the community should have access to hospital pharmacists for help
with dealing with patients with complex treatment regimens, according to Norman
Lannigan, lead pharmacist for acute care, mental health and innovation at NHS
Greater Glasgow and Clyde
PJ 2008;280:142
Full Text
142 Minor ailments schemes could undermine self-care Pharmacy
minor ailments schemes can attract patients away from GPs to community pharmacies,
but should not compromise self-care, the National Public Health Service for Wales
has warned
PJ 2008;280:142
Full Text
143 Weight management role
promoted after data show obesity increases Just
under a quarter of all adults in England were classified as obese in 2006, representing
a 15 per cent increase on 1993 figures, a recent report from The Information
Centre reveals. And in the seven years up to 2006, prescriptions dispensed for
obesity rose more than eight-fold
PJ 2008;280:143
Full Text
143 Changes to how Scotland’s contract payments are made Arrangements
for claiming phase 3 contract preparation payments in Scotland have been changed
following delays to the distribution of one of the training packs that needs
to be completed
PJ 2008;280:143
Full Text
143 National campaign launched to reduce use
of antibiotics Patients should seek pharmacists’ advice about cough and cold remedies, rather than requesting antibiotics from their GP, the Government has stressed
PJ 2008;280:143
Full Text
143 Consider pharmacy role in alcohol treatment
services Community pharmacists’ potential to discuss alcohol misuse with patients opportunistically needs to be considered by those developing treatment services, according to the Welsh Assembly Government
PJ 2008;280:143
Full Text
143 Faculty of cancer pharmacy A new body — the Faculty of Cancer Pharmacy — has been launched by the British Oncology Pharmacy Association and the College of Pharmacy Practice
PJ 2008;280:143
Full Text
143 Genotyping supported by data Prospective
genotyping to determine which patients are susceptible to abacavir hypersensitivity
reactions is supported by data from a randomised trial
PJ 2008;280:143
Full Text
143 MR prednisone has benefits A
modified release formulation of prednisone has shown promising results in a randomised
rheumatoid arthritis trial published
PJ 2008;280:143
Full Text
144 New statin side effects
warning Additional side effects have been identified
for statins as a class, the Medicines and Healthcare products Regulatory Agency
announced this week in the February 2008 issue of Drug Safety Update. The agency
says that patients should be made aware that depression, sleep disturbances,
memory loss and sexual dysfunction could occur
PJ 2008;280:144
Full Text
144 Studies with negative results go unpublished Publication
of studies of antidepressant medicines is biased toward those studies with positive
results, which can have adverse consequences for future research, a study suggests
PJ 2008;280:144
Full Text
144 DDA opposed to responsible pharmacist regulations Details of how the concept of the responsible pharmacist will work should be laid out in professional guidance rather than in regulations, according to the Dispensing Doctors’ Association. This, it says, would cut down on bureaucracy that it fears would stop the professionals involved from acting in the best interests of patients
PJ 2008;280:144
Full Text
144 Bleeding risks with idraparinux Discovery
of increased bleeding risk for patients taking the activated factor X inhibitor
idraparinux has prompted the early termination of a 4,576-patient trial
PJ 2008;280:144
Full Text
144 Experimental prostate cancer vaccine Vaccination could form a key part of future prostate cancer prevention. Researchers have tested a vaccination strategy directed against prostate stem cell antigen — a potential therapeutic target — in prostate cancer-prone mice
PJ 2008;280:144
Full Text
144 Romiplostim lifts platelet counts Thrombopoiesis-stimulating protein romiplostim has shown benefit for people with chronic immune thrombocytopenic purpura — an autoimmune condition causing accelerated platelet destruction and reduced platelet production
PJ 2008;280:144
Full Text
144 Nanotechnology improves implants A nano-scale coating could help to disguise implant technologies from the body’s immune system, new research suggests
PJ 2008;280:144
Full Text
145 Adherence to thromboembolism
guidance poor Over half of hospital inpatients
are at risk of venous thromboembolism (VTE) but rates of appropriate prophylaxis
are low, according to a study involving 358 hospitals across 32 countries, including
the UK
PJ 2008;280:145
Full Text
145 Joint working with industry encouraged NHS
organisations and staff are encouraged to consider opportunities for joint working
with the pharmaceutical industry in a guidance document published by the Department
of Health last week
PJ 2008;280:145
Full Text
145Calcium channel blockers link to lower Parkinson’s risk Long-term use of calcium channel blockers has been shown to correlate with a reduced risk of Parkinson’s disease
PJ 2008;280:145
Full Text
145 Cardiovascular mortality changing across
Europe Patterns of cardiovascular mortality across
Europe are changing, a new study published online suggests
PJ 2008;280:145
Full Text
145 Thiazide diuretics offer better heart failure
protection Thiazide diuretics offer greater protection against heart failure than — and are at least as effective at lowering blood pressure as — calcium channel blockers, angiotensin-converting enzyme inhibitors and alpha-blockers for patients with hypertension as part of metabolic syndrome, say researchers
PJ 2008;280:145
Full Text
145 Drug spending rises but not as proportion
of total NHS cost NHS spending on medicines rose from over £5.3bn in 1997 to more than £10.7bn in 2006, according to the Office of Health Economics’s ‘Compendium of health statistics 2008’
PJ 2008;280:145
Full Text |
The
Pharmaceutical Journal